Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The revision label on the page was updated from v3.3.3 to v3.3.4. No substantive content or functionality changes were observed.
    Difference
    0.1%
    Check dated 2026-01-20T14:39:58.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added a Locations section listing California, Oklahoma, and Wisconsin; removed the HHS Vulnerability Disclosure link; updated revision to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T00:52:08.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2. No study content or critical page elements appear to be altered.
    Difference
    0.1%
    Check dated 2025-12-01T16:27:56.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.3.1 is displayed on the page, replacing v3.2.0. No study content or essential details appear to have changed.
    Difference
    0.1%
    Check dated 2025-11-24T11:11:51.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The government funding notice previously displayed on the page has been removed. This change does not affect the study details, eligibility criteria, or trial operations; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:11:31.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The changes appear to be minor visual/layout updates across the page with no changes to core study details, eligibility criteria, locations, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:47:21.000Z thumbnail image

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.